Bexarotene
6 NDCs across 6 manufacturers|5 Generic,1 Brand
Bexarotene is used to treat lymphoma, t-cell, cutaneous, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 29, 1999, and the first generic was approved Aug 12, 2014. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $50 million on Bexarotene across 7,109 claims for 1,105 beneficiaries.
Bexarotene is available as 6 NDCs from 6 manufacturers (5 generic, 1 brand), with NADAC prices from $5.60 to $116.45 per EA — the most expensive product costs about 21× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
5G / 1B
Manufacturers
6
competing in market
Price Spread
$5.60 – $116.45
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
6 manufacturers producing BEXAROTENE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TARGRETIN 75 MG CAPSULE | $116.4522 per EA | — |
BEXAROTENE 75 MG CAPSULE | $5.6022 per EA | — |
BEXAROTENE 75 MG CAPSULE | $5.6022 per EA | — |
BEXAROTENE 75 MG CAPSULE | $5.6022 per EA | — |
BEXAROTENE 75 MG CAPSULE | $5.6022 per EA | — |
BEXAROTENE 75 MG CAPSULE | $5.6022 per EA | — |
Frequently Asked Questions
What is Bexarotene used to treat?
Bexarotene is used to treat lymphoma, t-cell, cutaneous, per the National Library of Medicine's MED-RT classification.
When did Bexarotene become available as a generic?
FDA approved the first generic Bexarotene (ANDA) on Aug 12, 2014. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Bexarotene?
In 2024, Medicare Part D spent $50 million on Bexarotene across 7,109 claims for 1,105 beneficiaries.
How many Bexarotene products are on the market?
The Bexarotene drug market contains 6 NDCs from 6 manufacturers — 5 generic and 1 brand product.
What is the price range for Bexarotene?
NADAC reference prices for Bexarotene range from $5.6022 to $116.4522 per EA — the most expensive product costs about 21× the cheapest.
Is generic Bexarotene cheaper than brand?
The average generic NADAC for Bexarotene is $5.6022 per EA, versus $116.4522 for brand-labeled products — brand versions average about 21× the generic price.
Which manufacturers make Bexarotene?
6 manufacturers list Bexarotene in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (1), Upsher-Smith Laboratories LLC (1), ANI Pharmaceuticals, Inc. (1), Amneal Pharmaceuticals NY LLC (1), Mylan Pharmaceuticals Inc. (1).